Podocytopathies associated with familial partial lipodystrophy due to LMNA variants: report of two cases

Arch Endocrinol Metab. 2024 May 10:68:e230204. doi: 10.20945/2359-4292-2023-0204.

Abstract

Lipodystrophies are characterized by complete or selective loss of adipose tissue and can be acquired or inherited. Familial partial lipodystrophy (FPLD) is a hereditary lipodystrophy commonly caused by mutations in the LMNA gene. Herein, we report two cases of FPLD associated with podocytopathies. Patient 1 was diagnosed with FPLD associated with the heterozygous p.Arg482Trp variant in LMNA and had normal glucose tolerance and hyperinsulinemia. During follow-up, she developed nephroticrange proteinuria. Renal biopsy was consistent with minimal change disease. Patient 2 was diagnosed with FPLD associated with a de novo heterozygous p.Arg349Trp variant in LMNA. Microalbuminuria progressed to macroalbuminuria within 6 years and tonephrotic range proteinuria in the last year. He remained without diabetes and with hyperinsulinemia. Renal biopsy revealed focal segmental glomerulosclerosis not otherwise specified. This report provides further evidence of variable features of lipodystrophy associated with LMNA variants and the importance of long-term follow-up with evaluation of kidney dysfunction.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Humans
  • Lamin Type A* / genetics
  • Lipodystrophy, Familial Partial* / complications
  • Lipodystrophy, Familial Partial* / genetics
  • Male
  • Mutation
  • Podocytes / pathology

Substances

  • Lamin Type A
  • LMNA protein, human